Alexion Pharmaceuticals Inc.

(ALXN) Trade

By |

Profile

Alexion Pharmaceuticals specializes in developing and marketing drugs for life-threatening medical conditions. Its blockbuster product is Soliris, which is the only approved therapy for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, two ultra-rare blood disorders, and was recently approved in general myasthenia gravis. Strensiq and Kanuma target other ultra-rare metabolic diseases. Alexion's pipeline targets areas of high unmet need and complement-mediated disorders.

Contact Information

Website: www.alexion.com
Email: AdverseEventReporting@alexion.com
Main Phone: +1 203 272-2596
Address: 100 College Street
State: CT
City / Town: New Haven
Country: USA
Postal Code: 06510

Issuer Information

Exchange: NGS
CEO: Ludwig N. Hantson
Employees: 2525
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
$ 109.43 $ -3. (-2.67%)
Last Price 109.43 Change $ -3. Change % -2.67 Tick N/A
Bid 105.01 Bid Size 100.00 Ask 113.24 Ask Size 100.00
Open 111.59 High 112.24 Low 108.86 Prev Close 112.43
Last Trade Volume 2.1 mi 52 Wk Hi 140.77 52 Wk Low 102.10
Market Cap 24.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 223,096,632.00 EPS (TTM) 0.67 PE Ratio 163.30 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 15 64
Number of Buys 11 36
Number of Sells 4 28
Net Activity 24652 407343
Last 10 Buys Shares
Christopher J. Coughlin 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Last 10 Sell Shares
Brian Goff 1,000
Indrani Lall Franchini 1,000
Anne-Marie Law 1,000
John J. Orloff 1,000
Heidi L. Wagner 1,000
Julie O'Neill 1,000
Heidi L. Wagner 1,000
Brian Goff 1,000
Paul J. Clancy 1,000
Julie O'Neill 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 184 184 184 184
Low Target Price Estimate 115 115 115 115
Mean Target Price Estimate 158.29 158.29 158.29 158.29
Standard Deviation 17.09 17.09 17.09 17.09
Date of Most Recent Estimate 05/14/18 05/14/18 05/14/18 05/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 13 13 13
Moderate Buy 3 3 3 3
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.26 1.26 1.26 1.26